Dr. Mawududzi Gerda Sanvee
Assistentin / PostDoc

Mawududzi Gerda Sanvee

Philosophisch-Naturwissenschaftliche Fakultät

Departement Pharmazeutische Wissenschaften

Pharmazeutische Technologie

Assistentin / PostDoc

Departement Pharmazeutische Wissenschaften
Klingelbergstrasse 50
4056 Basel
Schweiz

gerda.sanvee@unibas.ch

Curriculum Vitae

Gerda Mawududzi Sanvee graduated with a Master of Science in Medical Biology at the University of Lausanne in 2014. She did her master work on polarized Wnt proteins secretion in breast cancer cells in the department of Pharmacology under the supervision of Prof. Vladimir Katanaev.

She joined the research group of Prof. Dr. Stephan Krähenbühl in Clinical Pharmacology and Toxicology as a PhD student end of 2014. Her work focused on molecular mechanisms of simvastatin-induced myopathy and insulin resistance. She obtained a Master of Science in Toxicology in 2017, and her PhD in 2019.

She is currently a Postdoctoral researcher in the division of Clinical Pharmacology and Toxicology. Her current research focuses on the in vitro and in vivo characterization of the regulation of mTORC2 signaling in simvastatin-induced myopathy.

Publikationen

Sanvee, G. M., Panajatovic, M., Bouitbir, D. J. und Krähenbühl, D. (2020) «Statins and Insulin Resistance», European cardiology, 15, S. e44. doi: 10.15420/ecr.2020.15.1.PO21.   
Sanvee, G. M., Bouitbir, J. und Krähenbühl, S. (2019) «Insulin prevents and reverts simvastatin-induced toxicity in C2C12 skeletal muscle cells», Scientific reports. Nature Publishing Group, 9(1), S. 7409. doi: 10.1038/s41598-019-43938-5.   edoc
Sanvee, G. M., Panajatovic, M. V., Bouitbir, J. und Krähenbühl, S. (2019) «Mechanisms of insulin resistance by simvastatin in C2C12 myotubes and in mouse skeletal muscle», Biochemical pharmacology. Elsevier, 164, S. 23-33. doi: 10.1016/j.bcp.2019.02.025.   edoc